Hepatitis C virus acquisition among injecting drug users: A cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004

Journal of Urban Health

Volumn 86, Issue 1, 2009, Pages 106-118

  Falster, Kathleen ^a,b   Kaldor, John M ^a   Maher, Lisa ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Epidemiology; Hepatitis C virus; Injecting cohorts; Injecting drug use

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; AUSTRALIA; COHORT ANALYSIS; EPIDEMIC; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEEDLE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PRISON; RISK FACTOR; SELF REPORT; SEROPREVALENCE; SYRINGE;

ADULT; AUSTRALIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; NEEDLE-EXCHANGE PROGRAMS; PREVALENCE; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 58649111961     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-008-9330-7     Document Type: Article

References (29)

1. SF Hurley DJ Jolley JM Kaldor 1997 Effectiveness of needle-exchange programmes for prevention of HIV infection Lancet 349 9068 1797 1800
2. Health Incomes International PTY LTD., National Centre in HIV Epidemiology and Clinical Research, Drummond M. Return on Investment in Needle and Syringe Programs in Australia: Final Report: Commonwealth Department of Health and Ageing; 2002.
3. M MacDonald M Law J Kaldor J Hales GJ Dore 2003 Effectiveness of needle and syringe programmes for preventing HIV transmission Int J Drug Policy 14 353 357
4. National Centre in HIV Epidemiology and Clinical Research. Australian NSP Survey National Data Report 1995-2002. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of NSW; 2003.
5. M MacDonald AD Wodak R Ali 1997 HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges Med J Aust 166 5 237 240
6. N Crofts JL Hopper DS Bowden AM Breschkin R Milner SA Locarnini 1993 Hepatitis C virus infection among a cohort of Victorian injecting drug users Med J Aust 159 4 237 241
7. MA MacDonald AD Wodak KA Dolan I van Beek PH Cunningham JM Kaldor 2000 Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997 Med J Aust 172 57 61
8. L Maher K Chant B Jalaludin P Sargent 2004 Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia J Gastroenterol Hepatol 19 10 1114 1120
9. L Maher B Jalaludin KG Chant 2006 Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia Addiction 101 10 1499 1508
10. I van Beek R Dwyer GJ Dore K Luo JM Kaldor 1998 Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study BMJ 317 7156 433 437
11. DC Des Jarlais T Perlis K Arasteh 2005 Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001 AIDS 19 suppl 3 S20 S25
12. RD Burt H Hagan RS Garfein K Sabin C Weinbaum H Thiede 2007 Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004 J Urban Health 84 3 436 454
13. F Baryarama R Bunnell W McFarland 2007 Estimating HIV incidence in voluntary counseling and testing clients in Uganda (1992-2003) J Acquir Immune Defic Syndr 44 1 99 105
14. TB Hallet B Zaba J Todd 2008 Estimating incidence from prevalence in generalised HIV epidemics: methods and validation PLoS Medicine 5 4 0611 0622
15. RL Stoneburner D Low-Beer GS Tembo TE Mertens G Asiimwe-Okiror 1996 Human immunodeficiency virus infection dynamics in east Africa deduced from surveillance data Am J Epidemiol 144 7 682 695
16. C Osmond MJ Gardner 1982 Age, period and cohort models applied to cancer mortality rates Stat Med 1 3 245 259
17. National Centre in HIV Epidemiology and Clinical Research. Australian NSP Survey National Data Report 2000-2004. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of NSW; 2005.
18. YL Chiu IT Yu TW Wong 2004 Time trends of female lung cancer in Hong Kong: age, period and birth cohort analysis Int J Cancer 111 3 424 430
19. H Hagan H Thiede DC Des Jarlais 2004 Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion Epidemiology 15 5 543 549
20. JA Hahn K Page-Shafer PJ Lum 2002 Hepatitis C virus seroconversion among young injection drug users: relationships and risks J Infect Dis 186 11 1558 1564
21. A Judd M Hickman S Jones 2005 Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study BMJ 330 7481 24 25
22. L Maher J Li B Jalaludin KG Chant JM Kaldor 2007 High hepatitis C incidence in injecting drug users: a policy failure Aust N Z J Public Health 31 1 30 35
23. H Hagan H Thiede NS Weiss SG Hopkins JS Duchin ER Alexander 2001 Sharing of drug preparation equipment as a risk factor for hepatitis C Am J Public Health 91 1 42 46
24. GM Hunter GV Stimson A Judd S Jones M Hickman 2000 Measuring injecting risk behaviour in the second decade of harm reduction: a survey of injecting drug users in England Addiction 95 9 1351 1361
25. T Butler M Levy K Dolan J Kaldor 2003 Drug use and its correlates in an Australian prisoner population Addict Res Theory 11 2 89 101
26. DC Des Jarlais K Dehne J Casabona 2001 HIV surveillance among injecting drug users AIDS 15 Suppl 3 S13 S22
27. L Topp J Iversen H Wand C Day J Kaldor L Maher 2008 Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey J Acquir Immune Defic Syndr 47 5 632 638
28. MW Tyndall S Currie P Spittal 2003 Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic AIDS 17 6 887 893
29. National Centre in HIV Epidemiology and Clinical Research. Australian NSP Survey National Data Report 2001-2005. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of NSW; 2006.